Simultaneous Versus Staged Total Hip Arthroplasty A Review

Total hip arthroplasty (THA) is considered one of the most effective treatments for hip arthritis, but the decision to perform simultaneous bilateral THA versus staged bilateral THA remains a source of controversy based primarily on the analysis of the risks and benefits of each approach. Many surgeons are reluctant to consider simultaneous total hip arthroplasty even though the procedure is associated with a shorter total hospitalization, shorter recovery and rehabilitation time, and decreased cost. However, in this review, we find that despite higher blood loss in the simultaneous group, there are no significant differences in terms of cardiopulmonary complications, thromboembolic events, stroke, surgical site infection, and rate of allogeneic transfusion between simultaneous and staged procedures. In addition, careful patient selection (ASA 1 and 2) can further minimize the risks of simultaneous bilateral total hip arthroplasty and increase the likelihood of consistent successful outcomes.